Greencore-Bakkavor deal clears key regulators and targets 16 January 2026 completion
Greencore Group plc has ticked off the big regulatory hurdles for its recommended acquisition of Bakkavor Group plc and now expects the scheme of arrangement to become effective on 16 January 2026. That is the point at which the deal will complete and Bakkavor will be part of the Greencore fold.
The standout news: the UK Competition and Markets Authority (CMA) has accepted Greencore’s remedy to sell its Bristol chilled soups and sauces site to Compleat Food Group, and the US Hart-Scott-Rodino (HSR) antitrust condition was satisfied on 2 December 2025. What remains is the Court sanction of the scheme and the usual mechanical steps.
CMA approval with a targeted divestment: why it matters
The CMA has accepted “undertakings in lieu” of a deeper investigation. In plain English, Greencore agreed to sell its Bristol chilled soups and sauces manufacturing site to Compleat Food Group to address competition concerns, rather than go through a lengthy Phase 2 probe. This is the fastest route to clearance and usually signals any competition issues have been neatly ring-fenced.
From an investor’s perspective, this is positive. The remedy is specific and limited to one site, rather than a broad-brush divestment. It removes a major source of deal risk and keeps the timetable intact.
US HSR clearance secured
The HSR Act is the US pre-merger notification regime. The condition linked to HSR was satisfied on 2 December 2025. That closes out the US competition angle and further de-risks completion.
What still needs to happen: Court sanction and mechanics
The transaction remains subject to the Court sanctioning the scheme and the formal delivery of the Court Order to the Registrar of Companies. Timings can move a little depending on the Court’s schedule, but the companies now expect to complete on 16 January 2026.
There is also a long-stop date of 11.59 p.m. on 16 November 2026, which is the outside date by which the scheme must be implemented, though the parties can agree to extend it with the Panel’s and, if required, the Court’s consent. That is a standard safety valve, not a signal of expected delay.
Transaction timetable and key dates for shareholders
Here is the current roadmap. The dates are indicative and tied to the Court timetable, but they anchor how the handover will work for Bakkavor shareholders.
| Event | Expected time/date |
|---|---|
| Publication of the Greencore Prospectus | 8 January 2026 |
| Court Hearing | 15 January 2026 |
| Scheme Record Time | 6.00 p.m. on 15 January 2026 |
| Last day of dealings in Bakkavor Shares | 15 January 2026 |
| Suspension of listing of Bakkavor Shares | By 7.30 a.m. on 16 January 2026 |
| Effective Date of the Scheme | 16 January 2026 |
| Cancellation of listing of Bakkavor Shares | By 8.00 a.m. on 19 January 2026 |
| Admission of New Greencore Shares and start of trading | By 8.00 a.m. on 19 January 2026 |
| Crediting of New Greencore Shares to CREST | On or as soon as possible after 8.00 a.m. on 19 January 2026, but not later than 14 days after the Effective Date |
| Latest date for cheques/settlement through CREST | 14 days after the Effective Date |
| Long-stop date | 11.59 p.m. on 16 November 2026 |
What Bakkavor shareholders should expect
Under a scheme of arrangement, Bakkavor shareholders are automatically transferred out and receive the agreed consideration at the Scheme Record Time. The precise mix and amount of consideration are not disclosed in this announcement, but the timetable shows the issue and admission of New Greencore Shares, so equity in Greencore forms part of the package.
The announcement also references a CVR Consideration (a contingent value right). The timing mechanics for any CVR are set out in the Scheme Document and are not detailed here. Settlement will work as follows:
- If you held Bakkavor shares in certificated form at the Scheme Record Time, payment of any CVR Consideration will be by cheque or electronic payment where a UK bank mandate is on file.
- If you held in CREST at the Scheme Record Time, settlement will be made electronically to the mandates held on the register. If Greencore cannot effect electronic payment for reasons outside its control, payment will be made by cheque.
Trading in Bakkavor shares will be suspended by 7.30 a.m. on 16 January 2026 and the listing cancelled by 8.00 a.m. on 19 January 2026. New Greencore Shares are scheduled to be admitted and start trading by 8.00 a.m. on 19 January 2026, with CREST accounts credited on or shortly after that time.
Board changes signal founder involvement
Following Greencore’s upcoming AGM, and subject to the scheme becoming effective, Agust Gudmundsson and Lydur Gudmundsson, currently non-executive directors of Bakkavor, will join the Combined Group’s board as non-executive directors under the Bakkavor Founder Relationship Agreement. That keeps founder insight in the tent, which can be helpful in customer relationships and integration, though investors will want clear governance lines and performance accountability.
My take: de-risked path to completion, with the usual final checks
This update is encouraging. The big swing factors in any UK merger – CMA and HSR – are now satisfied. The chosen CMA remedy looks tight and targeted, keeping the industrial logic of the deal intact while removing the bottleneck.
The remaining risks are procedural. The Court sanction is essential and the timetable is still marked as indicative. Integration, delivery of any CVR conditions and the logistics of settlement are standard but worth watching. The long-stop date at 16 November 2026 is normal housekeeping, not a red flag.
If you are a Bakkavor holder, your last day to deal is 15 January 2026 and you should be ready for your Bakkavor shares to be suspended the following morning. If you are moving into New Greencore Shares, expect admission and CREST crediting around 19 January 2026. The consideration terms are in the Scheme Document and Prospectus – if you need the fine print, they can be found here:
Jargon buster
- Scheme of arrangement – a court-approved process to acquire a company, binding all shareholders once sanctioned.
- Undertakings in lieu – remedies offered to the CMA to avoid a full Phase 2 investigation.
- HSR Act – the US pre-merger notification regime overseen by the FTC and DOJ.
- CREST – the UK’s electronic settlement system for shares.
- CVR (contingent value right) – an instrument that pays out based on future events or performance, subject to conditions.
Bottom line
Greencore and Bakkavor have cleared the heavy lifting on regulatory approvals and set a clear path to a 16 January 2026 completion, with new Greencore shares due to start trading by 19 January 2026. That is a strong signal the deal is on track, with only the Court’s rubber stamp and closing mechanics to go. Keep an eye on the Prospectus on 8 January 2026 for the final detail, and mark your diary for the key dates above.
